AVBP
ArriVent BioPharma, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | +6 | 17.31M | $600.66M | +10 | −4 |
| Q1 2026 | 63 | +7 | 15.17M | $349.66M | +10 | −3 |
| Q4 2025 | 56 | +3 | 14.51M | $292.04M | +3 | — |
| Q3 2025 | 14 | +1 | 10.75M | $198.25M | +2 | −1 |
| Q2 2025 | 10 | 0 | 7.02M | $152.80M | +2 | −2 |
| Q1 2025 | 7 | +1 | 1.69M | $31.28M | +2 | −1 |
| Q4 2024 | 6 | -1 | 1.52M | $40.62M | +1 | −2 |
| Q3 2024 | 6 | +4 | 925.82K | $21.76M | +4 | — |
| Q2 2024 | 2 | — | 247.05K | $4.58M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 597.16K | +154.2% | $14.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 597.16K | +154.2% | $14.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 216.63K | +1689.9% | $5.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Marshall Wace ✦ | 85.25K | New | $2.00M | 0.0% | New | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 85.25K | New | $2.00M | 0.0% | New | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 9.35K | New | $220,000 | 0.0% | New | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 8.78K | New | $206,213 | 0.0% | New | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 8.66K | New | $203,441 | 0.0% | New | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 8.66K | New | $203,441 | 0.0% | New | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 8.66K | New | $203,441 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $2.00M | 0.0% |
| Marshall Wace | $2.00M | 0.0% |
| T. Rowe Price | $220,000 | 0.0% |
| D. E. Shaw & Co. | $206,213 | 0.0% |
| AQR Capital Management | $203,441 | 0.0% |
| AQR Capital Management | $203,441 | 0.0% |
| AQR Capital Management | $203,441 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 138 holders, 42.02M shares, $965.37M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.